首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症癌症診斷

市場調查報告書

商品編碼

1609804

2025-2033 年日本癌症診斷市場報告（按產品、技術、應用、最終用戶和地區分類）

Japan Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年日本癌症診斷市場IMARC Group達到 13 億美元。由於生活方式的改變和遺傳因素，癌症發病率不斷上升，以及改善患者護理的診斷方法的發展是市場成長的主要驅動力。

癌症診斷涉及個別癌症的識別和表徵，包括各種方法和技術，如磁振造影 (MRI)、X 光以及血液、組織和遺傳樣本的實驗室檢查。這些診斷工具使醫療保健專家能夠精確檢測和評估體內的癌症狀況，從而促進準確的評估。此外，它們還使醫療保健提供者能夠根據疾病的獨特屬性量身定做治療方法，從而最佳化患者的治療結果。這種方法有助於完善治療選擇並制定個人化的治療方法。

日本癌症診斷市場趨勢：

在日本的癌症診斷市場，由於生活方式的改變、環境影響、人口老化和遺傳傾向等多種因素，癌症病例顯著激增。累積的基因突變和長期暴露於潛在致癌物質導致民眾癌症發生率上升。此外，不健康的生活方式選擇，例如不良的飲食習慣和有限的身體活動，也會增加罹患癌症的風險。值得注意的是，人們越來越傾向於早期檢測作為提高癌症治療效果的手段。對準確及時的癌症診斷以預防併發症的需求不斷增加，進一步推動了市場的擴張。此外，醫療保健服務可近性的改善在促進日本市場成長方面發揮關鍵作用。由於消費者對早期癌症檢測重要性的認知不斷提高，日本癌症診斷市場正在進一步成長。人們正在積極進行常規篩檢和診斷檢查，以主動監測自己的健康狀況。此外，醫療保健提供者和組織正在進行廣泛的宣傳活動，旨在教育公眾早期介入的優勢，從而鼓勵積極主動的就醫行為。此外，早期檢測不僅可以提高治療效果，還可以減輕與晚期癌症相關的整體醫療負擔。各國監管機構和醫療機構正在實施無障礙篩檢計劃，並強調及時癌症診斷的重要性。這些舉措正在激勵個人定期接受癌症篩檢，預計這將在預測期內推動區域市場的發展。

日本癌症診斷市場細分：

產品見解：

耗材
抗體
試劑盒和試劑
探頭
其他
儀器儀表
病理學儀器
影像儀器
切片儀器

技術見解：

體外診斷測試
聚合酶鍊式反應 (PCR)
原位雜合技術 (ISH)
免疫組織化學 (IHC)
新一代定序 (NGS)
微陣列
流式細胞儀
免疫測定
其他
影像學
磁振造影 (MRI)
電腦斷層掃描 (CT)
正子斷層掃描 (PET)
乳房X光檢查
超音波
切片技術

應用見解：

乳癌
肺癌
大腸直腸癌
黑色素瘤
其他

最終使用者見解：

醫院和診所
診斷實驗室
其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

到目前為止，日本癌症診斷市場的表現如何？
COVID-19 對日本癌症診斷市場有何影響？
日本癌症診斷市場依產品分類是怎樣的？
日本癌症診斷市場在技術上的分化是什麼？
日本癌症診斷市場在應用上的細分如何？
日本癌症診斷市場以最終用戶分類是怎樣的？
日本癌症診斷市場價值鏈的各個階段是什麼？
日本癌症診斷的關鍵促進因素和挑戰是什麼？
日本癌症診斷市場的結構如何？
日本癌症診斷市場的競爭程度如何？

本報告回答的關鍵問題：

到目前為止，日本癌症診斷市場的表現如何？
COVID-19 對日本癌症診斷市場有何影響？
日本癌症診斷市場依產品分類是怎樣的？
日本癌症診斷市場在技術上的分化是什麼？
日本癌症診斷市場在應用上的細分如何？
日本癌症診斷市場以最終用戶分類是怎樣的？
日本癌症診斷市場價值鏈的各個階段是什麼？
日本癌症診斷的關鍵促進因素和挑戰是什麼？
日本癌症診斷市場的結構如何？
日本癌症診斷市場的競爭程度如何？

耗材
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 抗體
  - 試劑盒和試劑
  - 探頭
  - 其他
- 市場預測（2025-2033）
儀器儀表
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 病理學儀器
  - 影像儀器
  - 切片儀器
- 市場預測（2025-2033）

第 7 章：日本癌症診斷市場 - 細分：技術

體外診斷測試
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 聚合酶鍊式反應 (PCR)
  - 原位雜合技術 (ISH)
  - 免疫組織化學 (IHC)
  - 新一代定序 (NGS)
  - 微陣列
  - 流式細胞儀
  - 免疫測定
  - 其他
- 市場預測（2025-2033）
影像學
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 磁振造影 (MRI)
  - 電腦斷層掃描 (CT)
  - 正子斷層掃描 (PET)
  - 乳房X光檢查
  - 超音波
- 2025-2033 年市場預測
切片技術
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 8 章：日本癌症診斷市場 - 細分：按應用分類

乳癌
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
肺癌
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
大腸直腸癌
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
黑色素瘤
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 9 章：日本癌症診斷市場 - 細分：按最終用戶分類

醫院和診所
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
診斷實驗室
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 10 章：日本癌症診斷市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 11 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 12 章：日本癌症診斷市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 13 章：附錄

簡介目錄

Product Code: SR112024A16297

Japan cancer diagnostics market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.6 Billion by 2033, exhibiting a growth rate (CAGR) of 12.2% during 2025-2033. The rising incidence of cancer, due to lifestyle shifts and genetic factors, and the development of diagnostic methods to improve patient care are among the primary drivers of the market growth.

Cancer diagnostics involve the identification and characterization of cancer in individuals, encompassing various methods and technologies like magnetic resonance imaging (MRI), X-rays, and laboratory examinations of blood, tissue, and genetic samples. These diagnostic tools enable healthcare experts to precisely detect and evaluate cancerous conditions within the body, facilitating accurate assessments. Additionally, they empower healthcare providers to customize treatments based on the unique attributes of the disease, thereby optimizing patient outcomes. This approach aids in refining treatment choices and crafting personalized therapeutic approaches.

Japan Cancer Diagnostics Market Trends:

In Japan's cancer diagnostics market, there is a notable surge in cancer cases driven by a multitude of factors, including shifts in lifestyle patterns, environmental influences, an aging population, and genetic predisposition. Accumulated genetic mutations and prolonged exposure to potential carcinogens have resulted in a rising incidence of cancer among the populace. Furthermore, unhealthy lifestyle choices such as poor dietary habits and limited physical activity are contributing to an increased risk of cancer. Notably, there is a growing inclination towards early detection as a means to enhance the effectiveness of cancer treatment. The heightened demand for precise and timely cancer diagnosis to prevent complications further fuels market expansion. Additionally, the improved accessibility to healthcare services plays a pivotal role in boosting market growth within Japan. The Japan cancer diagnostics market is further experiencing growth driven by an increasing awareness among consumers regarding the significance of early cancer detection. People are actively pursuing routine screenings and diagnostic examinations to proactively monitor their health status. Additionally, healthcare providers and organizations are conducting extensive awareness campaigns aimed at educating the public about the advantages of early intervention, thereby encouraging proactive healthcare-seeking behavior. Furthermore, early detection not only enhances treatment outcomes but also reduces the overall healthcare burden associated with advanced-stage cancer. Regulatory authorities and healthcare institutions in various countries are implementing accessible screening programs and emphasizing the importance of timely cancer diagnosis. These initiatives are motivating individuals to undergo regular cancer screenings, which is expected to fuel the regional market over the forecasted period.

Japan Cancer Diagnostics Market Segmentation:

Product Insights:

Consumables
Antibodies
Kits and Reagents
Probes
Others
Instruments
Pathology-based Instruments
Imaging Instruments
Biopsy Instruments

Technology Insights:

IVD Testing
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Others
Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Mammography
Ultrasound
Biopsy Technique

Application Insights:

Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

End User Insights:

Hospitals and Clinics
Diagnostic Laboratories
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan cancer diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan cancer diagnostics market?
What is the breakup of the Japan cancer diagnostics market on the basis of product?
What is the breakup of the Japan cancer diagnostics market on the basis of technology?
What is the breakup of the Japan cancer diagnostics market on the basis of application?
What is the breakup of the Japan cancer diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan cancer diagnostics market?
What are the key driving factors and challenges in the Japan cancer diagnostics?
What is the structure of the Japan cancer diagnostics market and who are the key players?
What is the degree of competition in the Japan cancer diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cancer Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cancer Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Cancer Diagnostics Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Antibodies
  - 6.1.3.2 Kits and Reagents
  - 6.1.3.3 Probes
  - 6.1.3.4 Others
- 6.1.4 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Pathology-based Instruments
  - 6.2.3.2 Imaging Instruments
  - 6.2.3.3 Biopsy Instruments
- 6.2.4 Market Forecast (2025-2033)

7 Japan Cancer Diagnostics Market - Breakup by Technology

7.1 IVD Testing
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Polymerase Chain Reaction (PCR)
  - 7.1.3.2 In Situ Hybridization (ISH)
  - 7.1.3.3 Immunohistochemistry (IHC)
  - 7.1.3.4 Next-generation Sequencing (NGS)
  - 7.1.3.5 Microarrays
  - 7.1.3.6 Flow Cytometry
  - 7.1.3.7 Immunoassays
  - 7.1.3.8 Others
- 7.1.4 Market Forecast (2025-2033)
7.2 Imaging
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Magnetic Resonance Imaging (MRI)
  - 7.2.3.2 Computed Tomography (CT)
  - 7.2.3.3 Positron Emission Tomography (PET)
  - 7.2.3.4 Mammography
  - 7.2.3.5 Ultrasound
- 7.2.4 Market Forecast 2025-2033
7.3 Biopsy Technique
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Cancer Diagnostics Market - Breakup by Application

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Colorectal Cancer
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Melanoma
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Cancer Diagnostics Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Cancer Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Cancer Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis